サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1513992

幹細胞の世界市場

Stem Cells

出版日
ページ情報
英文 369 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
幹細胞の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 369 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

幹細胞の世界市場は2030年までに213億米ドルに達する見込み

2023年に129億米ドルと推定される幹細胞の世界市場は、2023年から2030年にかけてCAGR 7.4％で成長し、2030年には213億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるアダルト幹細胞は、CAGR 7.2%を記録し、分析期間終了時には178億米ドルに達すると予測されます。その他の製品タイプセグメントの成長率は、分析期間でCAGR 8.5％と推定されます。

米国市場は35億米ドルと推定、中国はCAGR 6.8％で成長予測

米国の幹細胞市場は2023年に35億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに33億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは6.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.0％と6.0％と予測されています。欧州では、ドイツがCAGR約6.0％で成長すると予測されています。

幹細胞-主要動向と促進要因

幹細胞は再生医療の要であり、広範な疾患や傷害の治療に計り知れない可能性を提供します。これらの細胞は、生後間もない時期や成長過程において、体内の様々な種類の細胞に成長するユニークな能力を持っており、一種の体内修復システムとしての役割を果たしています。幹細胞には、初期段階の胚に由来する胚性幹細胞と、様々な組織や臓器に存在する成体幹細胞があります。胚性幹細胞は多能性であり、体内のどのような細胞タイプにも変化することができますが、成体幹細胞は一般的に多能性であり、その起源組織に関連する狭い範囲の細胞タイプに分化することに限定されます。人工多能性幹細胞（iPSC）は、胚性幹細胞のような状態に遺伝的に再プログラムされた成体幹細胞の一種であり、この分野における重要な進歩の象徴です。iPSCは、胚ではなく成体細胞から作られるため、関連する倫理的懸念なしに胚性幹細胞の多様性を提供します。iPS細胞は、移植治療のための新しい細胞の作製や、薬物試験のための疾患モデル、ヒトの初期発生の研究などに利用することができ、ヒトの生物学や潜在的治療法に関する貴重な知見を提供します。

幹細胞研究分野は、過去数十年の間に急速な進歩を遂げ、多大な投資が行われてきました。CRISPR-Cas9遺伝子編集や3Dバイオプリンティングのような幹細胞技術におけるブレークスルーは、科学的探求と臨床応用への新たな道を開いた。CRISPR-Cas9はDNAの正確な操作を可能にし、研究者が幹細胞の遺伝的欠陥を修正したり、複雑な病態を研究するための疾患モデルを作ったりすることを可能にします。この技術は、個々の患者の遺伝子プロファイルに合わせた治療を行う個別化医療の進展に役立っています。一方、3Dバイオプリンティングは、幹細胞から複雑な組織構造を構築することを可能にし、組織工学や再生治療に用いることができます。これらの技術により、幹細胞の精密な操作が可能となり、研究者は遺伝的欠陥の修正、疾病メカニズムの詳細な研究、再生治療用の複雑な組織構造の作成が可能となります。幹細胞を用いた臨床試験は拡大しつつあり、パーキンソン病、脊髄損傷、心臓病、糖尿病などの治療への応用が検討されています。例えば、幹細胞治療は、心臓発作後に損傷した心臓組織を再生する可能性が検討されており、重篤な心血管疾患を抱える患者に新たな希望をもたらしています。さらに、幹細胞バンクやバイオリポジターが設立されたことで、研究や治療を目的とした高品質な幹細胞の入手が容易になった。

幹細胞市場の成長は、いくつかの要因によって牽引されています。CRISPR-Cas9やその他の遺伝子編集ツールの開発などの技術的進歩により、幹細胞治療の精度と有効性が向上し、臨床利用がより現実的になった。このような研究開発により、遺伝子レベルで疾患の根本原因に対処できる標的療法が開発できるようになった。慢性疾患や変性疾患の増加により、幹細胞治療の市場も拡大しています。アルツハイマー、多発性硬化症、変形性関節症などの疾患は、幹細胞研究が活発に進められている分野です。再生医療に対する認識と受容の高まりを含む消費者行動の動向も、市場の成長を後押ししています。患者やヘルスケアプロバイダーは、幹細胞治療がこれまで治療不可能であった疾患に対して革新的な治療を提供する可能性があることを認識しつつあります。加えて、政府および民間セクターからの多額の資金提供や有利な規制の枠組みが、この分野における研究開発活動を加速させています。幹細胞バンキングサービスの拡大や個別化医療のトレンドの高まりは、幹細胞を用いた治療に対する需要をさらに高めています。全体として、科学技術の革新、ヘルスケアニーズの高まり、そして支持的な規制・金融環境の融合が、幹細胞市場の力強い成長を後押ししています。

調査対象企業の例（注目の233社）

  • apceth Biopharma GmbH
  • Athersys Inc.
  • AVIVA BioSciences Corporation
  • BioE Inc.
  • Bone Therapeutics SA
  • Cesca Therapeutics Inc.
  • Cryo-Cell International Inc.
  • Cytori Therapeutics Inc.
  • ESI BIO
  • Gamida Cell Ltd.
  • Holostem Terapie Avanzate
  • International Stem Cell Corp.
  • Kangstem Biotech. Ltd.
  • Lonza Group Ltd.
  • Mesoblast Ltd.
  • Neuralstem Inc.
  • Nuvasive Inc.
  • OncoMed Pharmaceuticals Inc.
  • Osiris Therapeutics Inc.
  • Promethera Biosciences S.A.N.V
  • Reliance Life Sciences
  • ReNeuron Group Plc.
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takara Bio USA Inc.
  • TiGenix NV
  • U.S Stem Cell Inc.
  • ViaCord

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-6142

Global Stem Cells Market to Reach US$21.3 Billion by 2030

The global market for Stem Cells estimated at US$12.9 Billion in the year 2023, is expected to reach US$21.3 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Adult Stem Cells, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$17.8 Billion by the end of the analysis period. Growth in the Other Product Types segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 6.8% CAGR

The Stem Cells market in the U.S. is estimated at US$3.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.0% CAGR.

Stem Cells - Key Trends and Drivers

Stem cells are a cornerstone of regenerative medicine, offering immense potential for treating a wide range of diseases and injuries. These cells have the unique ability to develop into many different cell types in the body during early life and growth, serving as a sort of internal repair system. There are two primary types of stem cells: embryonic stem cells, which are derived from early-stage embryos, and adult stem cells, which are found in various tissues and organs. Embryonic stem cells are pluripotent, meaning they can turn into any cell type in the body, whereas adult stem cells are typically multipotent, limited to differentiating into a narrower range of cell types related to their tissue of origin. Induced pluripotent stem cells (iPSCs), a type of adult stem cell that has been genetically reprogrammed to an embryonic stem cell-like state, represent a significant advancement in the field. iPSCs offer the versatility of embryonic stem cells without the associated ethical concerns, as they are created from adult cells rather than embryos. Stem cells can be used to generate new cells for transplant therapies, model diseases for drug testing, and study early human development, providing invaluable insights into human biology and potential treatments.

The stem cell research field has seen rapid advancements and significant investment over the past few decades. Breakthroughs in stem cell technologies, such as CRISPR-Cas9 gene editing and 3D bioprinting, have opened new avenues for scientific exploration and clinical application. CRISPR-Cas9 allows for precise manipulation of DNA, enabling researchers to correct genetic defects in stem cells and create disease models for studying complex conditions. This technology has been instrumental in advancing personalized medicine, where treatments are tailored to the genetic profile of individual patients. 3D bioprinting, on the other hand, allows for the construction of complex tissue structures from stem cells, which can be used for tissue engineering and regenerative therapies. These technologies enable precise manipulation of stem cells, allowing researchers to correct genetic defects, study disease mechanisms in detail, and create complex tissue structures for regenerative therapies. Clinical trials involving stem cells are expanding, with numerous studies exploring their use in treating conditions such as Parkinson’s disease, spinal cord injuries, heart disease, and diabetes. For example, stem cell therapy is being investigated for its potential to regenerate damaged heart tissue following a heart attack, offering a new hope for patients with severe cardiovascular diseases. Moreover, the establishment of stem cell banks and biorepositories has facilitated easier access to high-quality stem cell lines for research and therapeutic purposes.

The growth in the stem cells market is driven by several factors. Technological advancements, such as the development of CRISPR-Cas9 and other gene-editing tools, have enhanced the precision and efficacy of stem cell therapies, making them more viable for clinical use. These advancements have enabled researchers to develop targeted therapies that can address the root causes of diseases at the genetic level. The increasing prevalence of chronic diseases and degenerative conditions has expanded the addressable market for stem cell treatments, as these therapies offer hope for conditions that currently lack effective treatments. Diseases such as Alzheimer's, multiple sclerosis, and osteoarthritis are areas where stem cell research is actively being pursued. Consumer behavior trends, including rising awareness and acceptance of regenerative medicine, have also propelled market growth. Patients and healthcare providers are increasingly recognizing the potential of stem cell therapies to provide innovative treatments for previously untreatable conditions. Additionally, substantial funding from government and private sectors, along with favorable regulatory frameworks, has accelerated research and development activities in the field. The expansion of stem cell banking services and the growing trend of personalized medicine have further fueled demand for stem cell-based therapies. Overall, the convergence of scientific innovation, increasing healthcare needs, and supportive regulatory and financial environments is driving robust growth in the stem cell market.

Select Competitors (Total 233 Featured) -

  • apceth Biopharma GmbH
  • Athersys Inc.
  • AVIVA BioSciences Corporation
  • BioE Inc.
  • Bone Therapeutics SA
  • Cesca Therapeutics Inc.
  • Cryo-Cell International Inc.
  • Cytori Therapeutics Inc.
  • ESI BIO
  • Gamida Cell Ltd.
  • Holostem Terapie Avanzate
  • International Stem Cell Corp.
  • Kangstem Biotech. Ltd.
  • Lonza Group Ltd.
  • Mesoblast Ltd.
  • Neuralstem Inc.
  • Nuvasive Inc.
  • OncoMed Pharmaceuticals Inc.
  • Osiris Therapeutics Inc.
  • Promethera Biosciences S.A.N.V
  • Reliance Life Sciences
  • ReNeuron Group Plc.
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takara Bio USA Inc.
  • TiGenix NV
  • U.S Stem Cell Inc.
  • ViaCord

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Stem Cells - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technological Advancements in CRISPR-Cas9 Gene Editing Propel Growth
    • Rise of 3D Bioprinting Expands Addressable Market Opportunity
    • Increasing Prevalence of Chronic and Degenerative Diseases Drives Demand
    • Establishment of Stem Cell Banks Generates Long-Term Market Opportunities
    • Advancements in Stem Cell Culture and Differentiation Techniques Accelerate Market Growth
    • Expansion of Clinical Trials for Diverse Therapeutic Applications Drives Adoption
    • Consumer Awareness and Acceptance of Regenerative Medicine Impacts Market Dynamics
    • Integration of AI and Machine Learning in Stem Cell Research Enhances Precision and Efficacy
    • Ethical and Legal Considerations Create Challenges and Opportunities
    • Impact of Global Health Trends on Stem Cell Therapy Adoption
    • Development of Novel Delivery Systems for Stem Cell Therapies Generates Demand
    • Innovations in Disease Modeling and Drug Testing Using Stem Cells Drive Market Dynamics
    • Growing Demand for Tissue Engineering and Regenerative Medicine Applications Expands Market Scope
    • Influence of Biobanks and Biorepositories on Research and Therapeutic Access
    • Emergence of New Stem Cell Sources and Types Impact the Market
    • Advancements in Immunotherapy and Cancer Treatments Using Stem Cells Propel Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Stem Cells Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 12: USA Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 13: USA 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 14: USA Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 17: Canada 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Canada 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • JAPAN
    • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Japan 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • CHINA
    • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 24: China Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: China 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 26: China Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • EUROPE
    • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 28: Europe Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: Europe 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • FRANCE
    • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 34: France Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: France 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 36: France Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: France 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • GERMANY
    • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Germany 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • ITALY
    • TABLE 42: Italy Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Italy 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • UNITED KINGDOM
    • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 46: UK Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: UK 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 48: UK Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: UK 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Asia-Pacific 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of World 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2024 & 2030
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of World 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2024 & 2030

IV. COMPETITION